跳至主要内容
临床试验/JPRN-UMIN000043098
JPRN-UMIN000043098招募中未知

Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remission - TRUST study

Sapporo Medical University0 个研究点目标入组 150 人开始时间: 2021年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients for whom a definitive diagnosis of ulcerative colitis has not been obtained 2. Proctitis type patients 3. Patients who have been administered either IFX / BS1 / BS2 in the past (However, cases in which treatment was discontinued after achieving remission by IFX / BS1 / BS2 treatment are excluded only when the same preparation is restarted due to relapse) 4. Patients who have been treated with adalimumab or golimumab in the past and have been primarily ineffective 5. Patients with a history of colectomy 6. Patients with or have a history of malignant disease 7. Patients with serious infectious diseases 8. Others who are judged by the principal investigator to be inappropriate as research subjects

研究者

相似试验